Skip to content
SABSSAB Biotherapeutics, Inc.

SABS holders

Who holds SAB Biotherapeutics, Inc., from the managers’ Form 13F reports for the quarter ended Sep 30, 2026.

Managers
107
Shares held
79.2M
Value held
$248.1M
Opened
22
Closed
7

Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.

ManagerSharesChangeValueOf portfolioFiled
First PREMIER Bank19K±0%$600.1%Oct 13, 2026
SJS Investment Consulting Inc.14New$450%Oct 26, 2026
Root Financial Partners, LLC3New$100%Oct 21, 2026
EverSource Wealth Advisors, LLC2New$60%Nov 4, 2026
Toronto Dominion Bank300±0%$40%Nov 16, 2026
HRT Financial LP44.8KNew$00%Nov 13, 2026
Virtu Financial LLC11.4K−46.1%$00%Nov 17, 2026